REFERENCES
- U. S. Environmental Protection Agency, Proposed guidelines for carcinogen risk assessment: Notice. Fed. Reg. 1996; 61(79)17,995–18,011
- U. S. Environmental Protection Agency, Draft Report. A cross-species scaling factor for carcinogen risk assessment based on equivalence of mg/kg3/4/day. Fed. Reg. 1992; 57(109)24,152–24,173
- Allen B. C., Crump K. S., Shipp A. M. Correlation between carcinogenic potency of chemicals in animals and humans. Risk Anal. 1988; 8: 531–544
- Gaylor D. W., Chen J. J., Sheehan D. M. Uncertainty in cancer risk estimates. Risk Anal. 1993; 13: 149–154
- Gaylor D. W., Gold L. S. Regulatory cancer risk assessment based on a quick estimate of a benchmark dose derived from the maximum tolerated dose. Regul. Toxicol. Pharmacol 1998; 28: 222–225
- Barnes D. G., Dourson M. Reference dose (RfD): Description and use in health risk assessments. Regul. Toxiocol. Pharmacol. 1988; 8: 471–486
- Purchase I. F. H., Auton R. T. Thresholds in chemical carcinogenesis. Regul. Toxicol. Pharmacol. 1995; 22: 199–205
- Crump K. S. The linearized multistage model and the future of quantitative risk assessment. Hum. Exp. Toxicol. 1996; 15: 787–798
- Gaylor D. W., Kodell R. L., Chen J. J., Krewski D. A unified approach to risk assessment for cancer and noncancer endpoints based on benchmark doses and uncertainty factors. Regul. Toxicol. Pharmacol 1999; 29: 151–157
- Rodricks J. V., Brett S., Wrenn G. Significant risk decisions in federal regulatory agencies. Regul. Toxicol. Pharmacol. 1987; 7: 307–320
- Travis C. C., Richter S. A., Crouch E. A. C., Wilson R., Klema E. D. Cancer risk management. Environ. Sci. Technol. 1987; 21: 415–420
- U. S. Environmental Protection Agency. General Quantitative Risk Assessment Guidelines for Noncancer Health Effects. ECAD-CIN-538, Environmental Criteria Assessment Office, Cincinnati, OH 1991
- Baird S. J. S., Cohen J. T., Graham J. D., Shlyakhter A. I., Evans J. S. Noncancer risk assessment: A probabilistic alternative to current practice. Hum. Ecol. Risk Assess. 1996; 2: 79–102
- Gaylor D. W., Kodell R. L. Percentiles of the product of uncertainty factors for establishing probabilistic reference doses. Risk Anal. 2000; 20
- Kodell R. L., Chen J. J., Gaylor D. W. A note on the role of background tumor incidence in risk assessment for carcinogens. Regul. Toxicol. Pharmacol. 1989; 9: 141–146
- Sielken R. L., Stevenson D. E. Another flaw in the linearized multistage model upper bounds on human cancer potency. Regul. Toxiocol. Pharmacol. 1994; 19: 106–114